[Intensity-modulated radiation therapy for breast cancer]
Rodríguez B, Augustovski F, Pichon-Riviere A, García Martí S, Alcaraz A, Bardach A, Ciapponi A
Record ID 32017000290
Spanish
Authors' recommendations:
No good quality evidence was found assessing the long-term effect of intensity-modulated radiation therapy for breast cancer.
Low quality evidence (from one randomized comparative study) shows that it would not be better than three-dimensional radiation therapy when considering outcomes such as overall survival, disease-free survival, local recurrence or serious adverse effects. Moderate quality evidence suggests that it would reduce skin scaling and have some cosmetic improvement, although its effect on quality of life is still uncertain.
The clinical practice guidelines assessed, mentioning intensity-modulated radiation therapy, do not recommend its use as routine practice and they restrict it to specific cases when excess toxicity with standard techniques is foreseen.
Although some health sponsors definitely do not consider its coverage, others cover it when standard radiation therapy assumes greater toxicity to the surrounding healthy organs.
Details
Project Status:
Completed
Year Published:
2017
URL for published report:
www.iecs.org.ar/home-ets/
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Argentina
MeSH Terms
- Breast Neoplasms
- Radiotherapy, Intensity-Modulated
Contact
Organisation Name:
Institute for Clinical Effectiveness and Health Policy
Contact Address:
Dr. Emilio Ravignani 2024, Buenos Aires - Argentina, C1414 CABA
Contact Name:
info@iecs.org.ar
Contact Email:
info@iecs.org.ar
Copyright:
Institute for Clinical Effectiveness and Health Policy (IECS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.